Alternate aggregation pathways of the Alzheimer β-amyloid peptide: Aβ association kinetics at endosomal pH

Journal of Molecular Biology

Volumn 325, Issue 4, 2003, Pages 743-757

  Gorman, Paul M ^a   Yip, Christopher M ^b   Fraser, Paul E ^a,c   Chakrabartty, Avijit ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Alzheimer's disease; Amyloid; Atomic force microscopy; Electron microscopy; Fibrillogenesis

Indexed keywords

AMYLOID; AMYLOID BETA PROTEIN;

ALPHA HELIX; ALZHEIMER DISEASE; ARTICLE; ATOMIC FORCE MICROSCOPY; CHEMICAL REACTION KINETICS; CIRCULAR DICHROISM; ENDOSOME; ENERGY TRANSFER; FLUORESCENCE; HYDRODYNAMICS; LIGHT SCATTERING; PH; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN STRUCTURE; SPECTROSCOPY; TIME;

EID: 0037462946     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2836(02)01279-2     Document Type: Article

References (47)

1. Sipe J.D., Cohen A.S. Review: history of the amyloid fibril. J. Struct. Biol. 130:2000;88-98.
2. Alzheimer A. Uber eine eigenartige erkrankung der hirnrinde. Allegemeine Zeitschrift Psychiatrie Psychisch-Gerichtliche medizin. 64:1907;146-148.
3. Selkoe D.J. The molecular pathology of Alzheimer's disease. Neuron. 6:1991;487-498.
4. Müller-Hill B., Beyreuther K. Molecular biology of Alzheimer's disease. Annu. Rev. Biochem. 58:1989;287-307.
5. Pike C.J., Burdick D., Walencewicz A.J., Glabe C.G., Cotman C.W. Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assemble state. J. Neurosci. 13:1993;1676-1687.
6. Simmons L.K., May P.C., Tomaselli K.J., Rydel R.E., Fuson K.S., Brigham E.F., et al. Secondary structure of amyloid beta peptide correlates with neurotoxic activity in vitro. Mol. Pharmacol. 45:1993;373-379.
7. Lorenzo A., Yankner B. Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red. Proc. Natl Acad. Sci. USA. 91:1994;12243-12247.
8. Chartier-Harlin M.C., Crawford F., Houlden H., Warren A., Hughes D., Fidani L., et al. Early-onset Alzheimer's disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene. Nature. 353:1991;844-846.
9. Mullan M., Crawford F., Axelman K., Houlden H., Lilius L., Winblad B., Lannfelt L. A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid. Nature Genet. 1:1992;345-347.
10. Levy-Lahad E., Wasco W., Poorkaj P., Romano D.M., Oshima J., Pettingell W.H., et al. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science. 269:1995;973-977.
11. Sherrington R., Rogaev E.I., Liang Y., Rogaeva E.A., Levesque G., Ikeda M., et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature. 375:1995;754-760.
12. Selkoe D.J. Alzheimer's disease: genotypes, phenotypes and treatments. Science. 275:1997;630-631.
13. Hardy J. Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci. 20:1997;154-159.
14. Lambert M.P., Barlow A.K., Chromy B.A., Edwards C., Freed R., Liosatos M., et al. Diffusible nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc. Natl Acad. Sci. USA. 95:1998;6448-6453.
15. Walsh D.M., Klyubin I., Fadeeva J.V., Cullen W.K., Anwyl R., Wolfe M.S., et al. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature. 416:2002;535-539.
16. Lansbury P.T. Jr. Evolution of amyloid: what normal protein folding may tell us about fibrillogenesis and disease. Proc. Natl Acad. Sci. USA. 96:1999;3342-3344.
17. Burdick D., Soreghan B., Kwon M., Kosmoski J., Knauer M., Henschen A., et al. Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs. J. Biol. Chem. 267:1992;546-554.
18. Hilbich C., Kister-Wolke B., Reed J., Masters C.L., Beyreuther K. Aggregation and secondary structure of synthetic amyloid beta A4 peptides of Alzheimer's disease. J. Mol. Biol. 218:1991;149-163.
19. Andreu J.M., De La Torre J., Carrascosa J.L. Interaction of tubulin with octyl glucoside and deoxycholate. 2. Protein conformation, binding of colchicines ligands, and microtubule assembly. Biochemistry. 25:1986;5230-5239.
20. Blow D.M., Chayen N.E., Lloyd L.F., Saridakis E. Control of nucleation of protein crystals. Protein Sci. 3:1994;1638-1643.
21. Eaton W.A., Hofrichter J. The biophysics of sickle cell hydroxyurea therapy. Science. 268:1995;1142-1143.
22. Harper J.D., Lansbury P.T. Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. Annu. Rev. Biochem. 66:1997;385-407.
23. Jarrett J.T., Berger E.P., Lansbury P.T. Jr. The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. Biochemistry. 32:1993;4693-4697.
24. Stine W.B. Jr, Snyder S.W., Ladror U.S., Wade W.S., Miller M.F., Perun T.J., et al. The nanometer-scale structure of amyloid-beta visualized by atomic force microscopy. J. Protein Chem. 15:1996;193-203.
25. Harper J.D., Wong S.S., Lieber C.M., Lansbury P.T. Observation of metastable Abeta amyloid protofibrils by atomic force microscopy. Chem. Biol. 4:1997;119-125.
26. Walsh D.M., Lomakin A., Benedek G.B., Condron M.M., Teplow D.B. Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate. J. Biol. Chem. 272:1997;22364-22372.
27. Blackley H.K., Sanders G.H., Davies M.C., Roberts C.J., Tendler S.J., Wilkinson M.J. In situ atomic force microscopy study of beta-amyloid fibrillization. J. Mol. Biol. 298:2000;833-840.
28. Nybo M., Svehag S., E, Nielsen E.H. An ultrastructural study of amyloid intermediates in Aβ1-42 fibrillogenesis. Scand. J. Immunol. 49:1999;219-223.
29. Huang T.H., Yang D.S., Plaskos N.P., Go S., Yip C.M., Fraser P.E., Chakrabartty A. Structural studies of soluble oligomers of the Alzheimer beta-amyloid peptide. J. Mol. Biol. 297:2000;73-87.
30. Chen W.J., Goldstein J.L., Brown M.S. NPXY, a sequence often found in cytoplasmic tails, is required for coated pit-mediated internalization of the low density lipoprotein receptor. J. Biol. Chem. 265:1990;3116-3123.
31. Haass C., Koo E.H., Mellon A., Hung A., Selkoe D.J. Targeting of cell-surface beta-amyloid precusor protein to lysosomes: alternative processing into amyloid-bearing fragments. Nature. 357:1992;500-503.
32. Koo E.H., Squazzo S.L., Selkoe D.J., Koo C.H. Trafficking of cell-surface amyloid beta-protein precursor, I. Secretion, endocytosis and recycling as detected by labeled monoclonal antibody. J. Cell Sci. 109:1996;991-998.
33. Hartmann T., Bieger S.C., Bruhl B., Tienari P.J., Ida N., Allsop D., et al. Distinct sites of intracellular production for Alzheimer's disease Abeta40/42 amyloid peptides. Nature Med. 3:1997;1016-1020.
34. Soriano S., Chyung A.S., Chen X., Stokin G.B., Lee V.M., Koo E.H. Expression of beta-amyloid precursor protein-CD3gamma chimeras to demonstrate the selective generation of amyloid beta(1-40) and amyloid beta(1-42) peptides within secretory and endocytic compartments. J. Biol. Chem. 274:1999;32295-32300.
35. Huse J.T., Liu K., Pijak D.S., Carlin D., Lee V.M., Doms R.W. Beta-secretase processing in the trans-Golgi network preferentially generates truncated amyloid species that accumulate in Alzheimer's disease brain. J. Biol. Chem. 277:2002;16278-16284.
36. Levine H. Thioflavine T interaction with synthetic Alzheimer's disease β-amyloid peptides: detection of amyloid aggregation in solution. Protein Sci. 2:1993;404-410.
37. Huang T.H.J., Fraser P.E., Chakrabartty A. Fibrillogenesis of Alzheimer beta-amyloid peptides studied by fluorescence energy transfer. J. Mol. Biol. 269:1997;214-224.
38. Walsh D.M., Hartley D.M., Kusumoto Y., Fezoui Y., Condron M.M., Lomakin A., et al. Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates. J. Biol. Chem. 274:1999;25945-25952.
39. Blanch E.W., Morozova-Roche L.A., Cochran D.A., Doig A.J., Hecht L., Barron L.D. Is polyproline II helix the killer conformation? A Raman optical activity study of the amyloidogenic prefibrillar intermediate of human lysozyme. J. Mol. Biol. 301:2000;553-563.
40. Wood S.J., Maleeff B., Hart T., Wetzel R. Physical, morphological and functional differences between pH 5.8 and 7.4 aggregates of the Alzheimer's amyloid peptide Aβ J. Mol. Biol. 256:1996;870-877.
41. Lomakin A., Teplow D.B., Kirschner D.A., Benedek G.B. Kinetic theory of fibrillogenesis of amyloid beta-protein. Proc. Natl Acad. Sci. USA. 94:1997;7942-7947.
42. Yong W., Lomakin A., Kirkitadze M.D., Teplow D.B., Chen S.H., Benedek G.B. Structure determination of micelle-like intermediates in amyloid beta-protein fibril assembly by using small angle neutron scattering. Proc. Natl Acad. Sci. USA. 99:2002;150-154.
43. Padrick S.B., Miranker A.D. Islet amyloid: phase partitioning and secondary nucleation are central to the mechanism of fibrillogenesis. Biochemistry. 41:2002;4694-4703.
44. Yamazaki T., Chang T.Y., Haass C., Ihara Y. Accumulation and aggregation of amyloid beta-protein in late endosomes of Niemann-pick type C cells. J. Biol. Chem. 276:2001;4454-4460.
45. Klein W.L., Krafft G.A., Finch C.E. Targeting small Abeta oligomers: the solution to an Alzheimer's disease conundrum? Trends Neurosci. 24:2001;219-224.
46. Edelhoch H. Spectroscopic determination of tryptophan and tyrosine in proteins. Biopolymers. 6:1967;1948-1954.
47. Hudson E.N., Weber G. Synthesis and characterization of two fluorescent sulfhydryl reagents. Biochemistry. 12:1973;4154-4161.